ATLANTA, Feb. 15, 2012 /PRNewswire/ -- Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, recently announced the appointment of Allen Fields, DrPH (Candidate) as Vice President, Head of R&D. Fields will be responsible for research and development, product development, clinical affairs, regulatory and technical affairs, quality and training.
Fields has more than 20 years of experience as a clinical and regulatory-affairs professional. He has managed IDEs, INDs, MAAs, NDAs, ANDAs, SNDAs, 510Ks, and PMAs, preparation, strategic clinical and regulatory planning, meetings with the global regulatory agencies, and drug development. He has held senior clinical and regulatory affairs positions at small and large pharmaceutical firms, and has been an independent consultant and a Director at Quintiles International.
Fields holds a B.S. in Chemistry from Kansas Wesleyan University; M.Ed. and M.S. work at Kansas State University; graduate work at University of Kansas School of Medicine; Neuropharmacology Fellowship at Duke University; and currently additional graduate work at John Hopkins University.
"We are excited to have Allen join our team," said Mark Pugh CEO of Acella Pharmaceuticals. "This appointment demonstrates our continued commitment to a growth strategy planned around excellence and strength. We look forward to developing Acella as a company of distinction, built with the highest caliber of talent in the market."
About Acella Pharmaceuticals, LLC.
Acella develops, markets, sells and distributes a broad portfolio of specialty pharmaceutical and other products in the areas of Dermatology, Women's Health, Pediatrics and other applications. Acella specializes in identifying and bringing to market quality, affordable products to customers and patients. For additional information please contact Acella at 678-325-5189.
SOURCE Acella Pharmaceuticals, LLC